Showing results (21-30 of 217) with videos related to
Sort By:
Pageof 22
Journal of Pharmacokinetics and Pharmacodynamics|June 30, 2009
Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithmJulie Bertrand, Emmanuelle Comets, Céline M Laffont, et al.The AAPS Journal|June 23, 2016
Improvement of Parameter Estimations in Tumor Growth Inhibition Models on Xenografted Animals: Handling Sacrifice Censoring and Error Caused by Experimental Measurement on Larger Tumor SizesPhilippe B Pierrillas, Michel Tod, Magali Amiel, et al.Clinical Pharmacokinetics|December 6, 2012
Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior informationCyrielle Dumont, France Mentré, Clare Gaynor, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 14, 2015
Model-based approaches for ivabradine development in paediatric population, part I: study preparation assessmentSophie Peigné, François Bouzom, Karl Brendel, et al.Antimicrobial Agents and Chemotherapy|October 25, 2003
Norfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamateMarylore Chenel, Anne Limosin, Sandrine Marchand, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 30, 2017
Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modellingKathryn Ball, Tanguy Jamier, Yannick Parmentier, et al.Antimicrobial Agents and Chemotherapy|December 27, 2005
Norfloxacin blood-brain barrier transport in rats is not affected by probenecid coadministrationSandrine Marchand, Anna Forsell, Marylore Chenel, et al.CPT: Pharmacometrics & Systems Pharmacology|October 28, 2021
Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approachElena M Tosca, Glenn Gauderat, Sylvain Fouliard, et al.ACS Pharmacology & Translational Science|January 15, 2026
Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) ModelingSalih Benamara, Erik Sjögren, Florence Gattacceca, et al.Journal of Pharmacokinetics and Pharmacodynamics|February 25, 2011
Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acidKayode Ogungbenro, Leon AaronsPageof 22